2 legendary ASX large-cap shares trading on hard-to-ignore valuations

These large stocks look good value to me.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX large-cap shares can be great investments due to their strong position in their industry and ability to deliver large profits.

With the S&P/ASX 200 Index (ASX: XJO) regularly hitting new all-time highs, it may be difficult to find investments that seem attractively priced.

But, there are a few areas of the market that look appealing.

I'm going to discuss two ASX large-cap shares that have seen their share prices decline over the past year, but their futures look promising.

A woman stands on a huge oversized wooden park bench with her arms outstretched towards the mountainous horizon in the distance.

Image source: Getty Images

Sonic Healthcare Ltd (ASX: SHL)

Sonic is a large, global pathology business with a presence in countries such as Australia, the USA, Germany, the UK, Switzerland and so on.

Over the past year, Sonic Healthcare's share price has fallen by 12%, compared to a 12% rise for the ASX 200.

It's understandable why the company has fallen due to a few factors, including inflation of costs and the loss of COVID-19 testing revenue.

But, I believe there are a number of positives that can help the company over the long-term. I'll mention a few of them now.

Sonic has made several acquisitions in Europe, particularly in Switzerland and Germany, to enhance its scale and presence in those regions. Sonic is currently working on unlocking synergies.

The ASX large-cap share has made equity investments in AI businesses, with those AI services potentially capable of improving Sonic's service and efficiencies.  

The last thing I'll point to is the ongoing solid organic base business revenue growth – in FY24 the growth rate was 6%.

According to the estimates on Commsec, the Sonic Healthcare share price is valued at under 22x FY26's estimated earnings with a forecast dividend yield of 4% (excluding franking credits).

Rio Tinto Ltd (ASX: RIO)

ASX iron ore shares can be opportunities when there is a significant weakness regarding the iron ore price. In 2024 to date, the Rio Tinto share price is down close to 20%.

Commodities can be cyclical opportunities if we buy when prices are low (and possibly sell when prices are higher).

There is no financial rule to say when the next rebound of the iron ore price will be, or by how much the price will rise.

However, there are some optimistic signs of a potential turnaround with President Xi Jinping urging China to strive to "achieve its annual economic and social development goals and tasks", raising market hopes for further stimulus, according to Trading Economics. It's also possible that China may soon cut interest rates for trillions of dollars of mortgages.

I'm also attracted to Rio Tinto's efforts to grow its copper exposure, which could be one of the most important commodities in the coming years because of its usage in things like electric vehicles and renewable energy.

The ASX large-cap share is valued at 10x FY26's estimated earnings with a possible fully franked dividend yield of 5.7% in FY26.

Motley Fool contributor Tristan Harrison has positions in Sonic Healthcare. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Blue Chip Shares

Why CSL shares could be one of the best buys on the ASX right now

CSL shares have been hammered by earnings disappointments. But the long-term investment case remains strong.

Read more »

A happy elderly couple enjoy a cuppa outdoors as the woman looks through binoculars.
Blue Chip Shares

The ageing Australia megatrend: 3 ASX shares built to benefit

With an ageing population, Australian companies must position themselves to provide services made for this demographic. These three stocks have…

Read more »

Workers inspecting a gas pipeline.
Dividend Investing

This overlooked ASX stock has raised its dividend 20 years in a row

20 years of consistent dividend growth is just the tip of the iceberg for this quality business.

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Blue Chip Shares

Where I'd invest $10,000 into ASX 200 dividend shares right now

These businesses look like compelling buys today.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Retail Shares

3 ASX retail shares exposed to a drop in consumer spending

Which stocks could be most impacted by a drop in consumer spending?

Read more »

A target on a red background surrounded by white arrows pointing to it.
Blue Chip Shares

2 high-quality ASX 200 shares experts rate as buys

Experts say these businesses are undervalued.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Blue Chip Shares

Why this ASX 200 blue-chip share could be an AI winner

Some companies sell AI tools. Others may create value by applying them across large customer bases and complex operations.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Blue Chip Shares

1 ASX blue chip stock I'd consider buying with the ASX 200 around 8,700

This healthcare business has exposure to a large underdiagnosed market, strong recent momentum, and a growing digital ecosystem.

Read more »